Platelet activity and outcome after intracerebral hemorrhage

There are few data on platelet function in intracerebral hemorrhage (ICH). We prospectively enrolled 69 patients with ICH and measured platelet function on admission. Aspirin use before ICH was associated with reduced platelet activity. Less platelet activity was associated with intraventricular hemorrhage (516.5 [interquartile range (IQR), 454–629.25] vs 637 [IQR, 493–654] aspirin reaction units; p = 0.04) and death at 14 days (480.5 [IQR, 444.5–632.5] vs 626 [IQR, 494–652] aspirin reaction units; p = 0.04). Objective measures of platelet function on admission are associated with intraventricular hemorrhage and death after ICH. Ann Neurol 2009;65:352–356

[1]  A. Jaffe,et al.  Aspirin responsiveness in healthy volunteers measured with multiple assay platforms. , 2008, Clinical chemistry.

[2]  C. Anderson,et al.  Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial , 2008, The Lancet Neurology.

[3]  A. Gori,et al.  Different methodologies for evaluating the effect of clopidogrel on platelet function in high‐risk coronary artery disease patients , 2007, Journal of thrombosis and haemostasis : JTH.

[4]  E. Oger,et al.  Antiplatelet drug use preceding the onset of intracerebral hemorrhage is associated with increased mortality , 2007, Fundamental & clinical pharmacology.

[5]  S. Mayer,et al.  Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage , 2007, Stroke.

[6]  S. Mayer,et al.  Dynamics of Intraventricular Hemorrhage in Patients with Spontaneous Intracerebral Hemorrhage: Risk Factors, Clinical Impact, and Effect of Hemostatic Therapy with Recombinant Activated Factor VII , 2006, Neurosurgery.

[7]  T. Neumann-Haefelin,et al.  Pretreatment With Antiplatelet Agents Is Not Independently Associated With Unfavorable Outcome in Intracerebral Hemorrhage , 2006, Stroke.

[8]  E. Savolainen,et al.  Regular Aspirin-Use Preceding the Onset of Primary Intracerebral Hemorrhage is an Independent Predictor for Death , 2006, Stroke.

[9]  S. Ibayashi,et al.  Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage , 2005, Neurology.

[10]  M. Gomis,et al.  Previous antiplatelet therapy is an independent predictor of 30–day mortality after spontaneous supratentorial intracerebral hemorrhage , 2005, Journal of Neurology.

[11]  H. Diener,et al.  Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial , 2004, The Lancet.

[12]  M. Alberts,et al.  Antiplatelet Effect of Aspirin in Patients With Cerebrovascular Disease , 2003, Stroke.

[13]  Joseph K McLaughlin,et al.  Nonaspirin Nonsteroidal Anti-Inflammatory Drugs and Risk of Hospitalization for Intracerebral Hemorrhage: A Population-Based Case-Control Study , 2003, Stroke.

[14]  Timothy W. Cooke,et al.  Improving the assessment of outcomes in stroke: use of a structured interview to assign grades on the modified Rankin Scale. , 2002, Stroke.

[15]  U. Schulz,et al.  Improving the Assessment of Outcomes in Stroke: Use of a Structured Interview to Assign Grades on the Modified Rankin Scale , 2002, Stroke.

[16]  E. Beard,et al.  The American Society of Health System Pharmacists. , 2001, JONA's Healthcare Law, Ethics, and Regulation.

[17]  G. Manley,et al.  The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. , 2001, Stroke.

[18]  J. McNeil,et al.  Risk of primary intracerebral haemorrhage associated with aspirin and non-steroidal anti-inflammatory drugs: case-control study , 1999, BMJ.

[19]  P. Whelton,et al.  Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. , 1998, JAMA.

[20]  T Brott,et al.  The ABCs of measuring intracerebral hemorrhage volumes. , 1996, Stroke.

[21]  K. Grotemeyer,et al.  Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients. , 1993, Thrombosis research.

[22]  L. Brace,et al.  Aspirin Response and Failure in Cerebral Infarction , 1993, Stroke.

[23]  J. Marler,et al.  Measurements of acute cerebral infarction: a clinical examination scale. , 1989, Stroke.

[24]  B Jennett,et al.  PREDICTING OUTCOME IN INDIVIDUAL PATIENTS AFTER SEVERE HEAD INJURY , 1976, The Lancet.

[25]  B. Jennett,et al.  Assessment of coma and impaired consciousness. A practical scale. , 1974, Lancet.

[26]  D. Atar,et al.  Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study. , 2007, Thrombosis research.

[27]  Using medication reconciliation to prevent errors. , 2006, Sentinel event alert.

[28]  J. Broderick,et al.  Early hemorrhage growth in patients with intracerebral hemorrhage. , 1997, Stroke.